FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372710003: Mydriatic (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1198005016 Mydriatic (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211234016 Mydriatic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1198005016 Mydriatic (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1198005016 Mydriatic (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211234016 Mydriatic en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1211234016 Mydriatic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Mydriatic Is a Muscarinic receptor antagonist false Inferred relationship Existential restriction modifier (core metadata concept)
    Mydriatic Has disposition Muscarinic receptor antagonist false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dipivefrine (substance) Is a False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Cyclopentolate (substance) Is a False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Hydroxyamfetamine hydrobromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 10 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 1% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely homatropine hydrobromide 10 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 20 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 2% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscine hydrobromide [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscine hydrobromide 0.25% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide 1% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide 0.5% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Medicinal product acting as mydriatic (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 0.031% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 0.062% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 0.1% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 0.25% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 5 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 1% preservative-free eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 20 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 0.125% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 0.25% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 0.5% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 1% preservative-free eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 2% preservative-free eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscine hydrobromide 0.125% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscine hydrobromide 0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine eye preparations (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 5 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 1% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 5% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide 0.5% ophthalmic solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide 1%/mL solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide 5mg solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Ophthalmic hyoscine hydrobromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Antispasmodic homatropine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydroxyamfetamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing tropicamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing lachesine chloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing homatropine methylbromide and hydrocodone bitartrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 10 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydroxyamphetamine hydrobromide and tropicamide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)
    Lachesine chloride (substance) Is a False Mydriatic Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Description inactivation indicator reference set

    GB English

    US English

    Back to Start